首页 > 最新文献

Russian Medical Inquiry最新文献

英文 中文
Neuropathic pain component in patients with osteoarthritis 骨关节炎患者的神经性疼痛成分
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-3-113-119
O. G. Filimonova
Background: chronic joint pain in osteoarthritis (OA) is an important factor of maladaptation. According to modern concepts, there are two variants presented in this pathology: nociceptive and nociplastic. Much less is known about the contribution of the neuropathic component (NC) to the pain syndrome formation. Aim: to study the pain syndrome patterns in patients with OA, as well as to identify NC in such patients and its impact on the life quality. Patients and Methods: the prospective study included 31 patients (mean age — 62.9±6.7 years, 26 (83.9%) women) with stage I–III OA of the knee and/or hip joint. The course of the articular syndrome corresponded to the pain syndrome course and ranged from 2 months to 30 years, averaging 10.6±9.9 years. All patients underwent general clinical examination. To detect neuropathic pain component (NPC), a neurological examination was performed using the DN4 and painDETECT questionnaires. The level of life quality was determined by the EQ-5D questionnaire. Results: NPC was detected in almost half (48%) of the examined patients. At the same time, the severity of radiological changes in the joints did not depend on its presence. However, in the presence of NC, the following manifestations were significantly more common in the area of the most affected joint (p<0.05): burning, numbness, electric shock, hypoesthesia, tingling, a feeling of crawling and/or tingling. There was practically no such symptom as itching, while the frequency of hypoesthesia in the groups did not significantly differ. According to the EQ-5D questionnaire, lower indicators were observed in patients with the NPC, their mobility assessment and daily activity were significantly worse. Mixed anxiety–depressive disorder were also observed (p<0.05) in such patients. Conclusion: for adequate treatment of pain syndrome, it is necessary to determine the presence of NPC in patients with OA and use antidepressants and anticonvulsants in complex therapy. KEYWORDS: osteoarthritis, chronic pain syndrome, nociceptive pain, nociplastic pain, neuropathic pain component, life quality. FOR CITATION: Filimonova O.G. Neuropathic pain component in patients with osteoarthritis. Russian Medical Inquiry. 2022;6(3):113–119 (in Russ.). DOI: 10.32364/2587-6821-2022-6-3-113-119.
背景:骨关节炎(OA)的慢性关节疼痛是适应不良的重要因素。根据现代概念,在这种病理中有两种变体:伤害性和伤害性。对神经性成分(NC)对疼痛综合征形成的贡献知之甚少。目的:研究骨性关节炎患者的疼痛综合征模式,鉴别骨性关节炎患者的NC及其对生活质量的影响。患者和方法:前瞻性研究包括31例I-III期膝关节和/或髋关节OA患者(平均年龄- 62.9±6.7岁,26例(83.9%)女性)。关节综合征病程与疼痛综合征病程相对应,从2个月到30年不等,平均10.6±9.9年。所有患者均进行了一般临床检查。为了检测神经性疼痛成分(NPC),采用DN4和painDETECT问卷进行神经学检查。生活质量水平由EQ-5D问卷确定。结果:近一半(48%)的患者检出鼻咽癌。同时,关节放射学改变的严重程度并不取决于它的存在。然而,在NC存在时,以下表现在最受影响的关节区域更为常见(p<0.05):灼烧、麻木、电击、感觉减退、刺痛、爬行和/或刺痛的感觉。几乎没有瘙痒等症状,而各组感觉减退的频率没有显着差异。根据EQ-5D问卷,鼻咽癌患者各项指标均较低,其流动性评估和日常活动能力明显差。患者还存在混合性焦虑抑郁障碍(p<0.05)。结论:为了充分治疗疼痛综合征,有必要确定OA患者是否存在鼻咽癌,并使用抗抑郁药和抗惊厥药进行综合治疗。关键词:骨关节炎,慢性疼痛综合征,伤害性疼痛,伤害性疼痛,神经性疼痛成分,生活质量。引文:Filimonova O.G.。骨关节炎患者的神经性疼痛成分。俄罗斯医学调查。2022;6(3):113-119(俄文)。DOI: 10.32364 / 2587-6821-2022-6-3-113-119。
{"title":"Neuropathic pain component in patients with osteoarthritis","authors":"O. G. Filimonova","doi":"10.32364/2587-6821-2022-6-3-113-119","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-3-113-119","url":null,"abstract":"Background: chronic joint pain in osteoarthritis (OA) is an important factor of maladaptation. According to modern concepts, there are two variants presented in this pathology: nociceptive and nociplastic. Much less is known about the contribution of the neuropathic component (NC) to the pain syndrome formation. Aim: to study the pain syndrome patterns in patients with OA, as well as to identify NC in such patients and its impact on the life quality. Patients and Methods: the prospective study included 31 patients (mean age — 62.9±6.7 years, 26 (83.9%) women) with stage I–III OA of the knee and/or hip joint. The course of the articular syndrome corresponded to the pain syndrome course and ranged from 2 months to 30 years, averaging 10.6±9.9 years. All patients underwent general clinical examination. To detect neuropathic pain component (NPC), a neurological examination was performed using the DN4 and painDETECT questionnaires. The level of life quality was determined by the EQ-5D questionnaire. Results: NPC was detected in almost half (48%) of the examined patients. At the same time, the severity of radiological changes in the joints did not depend on its presence. However, in the presence of NC, the following manifestations were significantly more common in the area of the most affected joint (p<0.05): burning, numbness, electric shock, hypoesthesia, tingling, a feeling of crawling and/or tingling. There was practically no such symptom as itching, while the frequency of hypoesthesia in the groups did not significantly differ. According to the EQ-5D questionnaire, lower indicators were observed in patients with the NPC, their mobility assessment and daily activity were significantly worse. Mixed anxiety–depressive disorder were also observed (p<0.05) in such patients. Conclusion: for adequate treatment of pain syndrome, it is necessary to determine the presence of NPC in patients with OA and use antidepressants and anticonvulsants in complex therapy. KEYWORDS: osteoarthritis, chronic pain syndrome, nociceptive pain, nociplastic pain, neuropathic pain component, life quality. FOR CITATION: Filimonova O.G. Neuropathic pain component in patients with osteoarthritis. Russian Medical Inquiry. 2022;6(3):113–119 (in Russ.). DOI: 10.32364/2587-6821-2022-6-3-113-119.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77859391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pathogenic aspects of the comorbid course of non-alcoholic fatty liver disease and cholelithiasis: a review and the authors’ results 非酒精性脂肪性肝病和胆石症共病过程的致病方面:综述和作者的结果
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-5-278-285
Т.С. Кролевец, М. А. Ливзан, М.И. Сыровенко, Н.А. Черкащенко, T. Krolevets, M. Livzan, M. I. Syrovenko, N. Cherkashchenko, Maria A. Livzan — Dr. Sc. Med
This paper reviews the pathogenic mechanisms of the development and progression of comorbid cholelithiasis (CL) and non-alcoholic fatty liver disease (NAFLD). The authors discuss gender and anatomic physiological patterns, and the effects of insulin resistance, obesity, adipose tissue hormones, and cholecystectomy on clinical morphological abnormalities in coexisting CL and NAFLD. In addition to lipid metabolism abnormalities, comorbid CL and NAFLD are characterized by deviations in the amount and proportions of fatty acids and hormonal imbalance (i.e., hyperleptinemia, leptin resistance, and insulin resistance). Cholecystectomy is an unfavorable factor for the progressive course of NAFLD and development of liver fibrosis. As a result, individualized management strategies are required in these cases. The authors present their own study that enrolled 183 patients with NAFLD. Their data demonstrate that coexisting NAFLD and CL have certain clinical laboratory signatures, while the postoperative period after cholecystectomy in patients with NAFLD is characterized by greater cardiovascular risk and liver fibrosis progression. The authors discuss the use of a combined preparation of ursodeoxycholic acid and sodium glycyrrhizinate in these patients. Two-component hepatoprotective treatment with this agent has pathogenically-target effect in comorbid NAFLD and CL. KEYWORDS: non-alcoholic fatty liver disease, cholelithiasis, comorbidity, liver fibrosis, cholecystectomy. FOR CITATION: Krolevets T.S., Livzan M.A., Syrovenko M.I., Cherkashchenko N.A. Pathogenic aspects of the comorbid course of non- alcoholic fatty liver disease and cholelithiasis: a review and the authors’ results. Russian Medical Inquiry. 2022;6(5):278–285 (in Russ.). DOI: 10.32364/2587-6821-2022-6-5-278-285.
本文综述了胆石症(CL)与非酒精性脂肪性肝病(NAFLD)并发的发病机制。作者讨论了性别和解剖生理模式,以及胰岛素抵抗、肥胖、脂肪组织激素和胆囊切除术对并发CL和NAFLD临床形态学异常的影响。除了脂质代谢异常外,合并CL和NAFLD还表现为脂肪酸数量和比例的偏差以及激素失衡(即高瘦素血症、瘦素抵抗和胰岛素抵抗)。胆囊切除术是NAFLD进展和肝纤维化发展的不利因素。因此,在这些情况下,需要个性化的管理策略。作者介绍了他们自己的研究,纳入了183名NAFLD患者。他们的数据表明,同时存在的NAFLD和CL具有一定的临床实验室特征,而NAFLD患者胆囊切除术后的术后阶段以更大的心血管风险和肝纤维化进展为特征。作者讨论了熊去氧胆酸和甘草酸钠联合制剂在这些患者中的应用。本品双组份保肝治疗对合并NAFLD和CL的患者具有致病靶点效应。关键词:非酒精性脂肪性肝病、胆石症、合并症、肝纤维化、胆囊切除术引用本文:Krolevets t.s., Livzan m.a., Syrovenko m.i.a., Cherkashchenko N.A.。非酒精性脂肪性肝病和胆石症共病过程的致病方面:综述和作者的结果。俄罗斯医学调查。2022;6(5):278-285(俄文)。DOI: 10.32364 / 2587-6821-2022-6-5-278-285。
{"title":"Pathogenic aspects of the comorbid course of non-alcoholic fatty liver disease and cholelithiasis: a review and the authors’ results","authors":"Т.С. Кролевец, М. А. Ливзан, М.И. Сыровенко, Н.А. Черкащенко, T. Krolevets, M. Livzan, M. I. Syrovenko, N. Cherkashchenko, Maria A. Livzan — Dr. Sc. Med","doi":"10.32364/2587-6821-2022-6-5-278-285","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-5-278-285","url":null,"abstract":"This paper reviews the pathogenic mechanisms of the development and progression of comorbid cholelithiasis (CL) and non-alcoholic fatty liver disease (NAFLD). The authors discuss gender and anatomic physiological patterns, and the effects of insulin resistance, obesity, adipose tissue hormones, and cholecystectomy on clinical morphological abnormalities in coexisting CL and NAFLD. In addition to lipid metabolism abnormalities, comorbid CL and NAFLD are characterized by deviations in the amount and proportions of fatty acids and hormonal imbalance (i.e., hyperleptinemia, leptin resistance, and insulin resistance). Cholecystectomy is an unfavorable factor for the progressive course of NAFLD and development of liver fibrosis. As a result, individualized management strategies are required in these cases. The authors present their own study that enrolled 183 patients with NAFLD. Their data demonstrate that coexisting NAFLD and CL have certain clinical laboratory signatures, while the postoperative period after cholecystectomy in patients with NAFLD is characterized by greater cardiovascular risk and liver fibrosis progression. The authors discuss the use of a combined preparation of ursodeoxycholic acid and sodium glycyrrhizinate in these patients. Two-component hepatoprotective treatment with this agent has pathogenically-target effect in comorbid NAFLD and CL. KEYWORDS: non-alcoholic fatty liver disease, cholelithiasis, comorbidity, liver fibrosis, cholecystectomy. FOR CITATION: Krolevets T.S., Livzan M.A., Syrovenko M.I., Cherkashchenko N.A. Pathogenic aspects of the comorbid course of non- alcoholic fatty liver disease and cholelithiasis: a review and the authors’ results. Russian Medical Inquiry. 2022;6(5):278–285 (in Russ.). DOI: 10.32364/2587-6821-2022-6-5-278-285.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77644671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New look on the use of sodium escinate in patients with post-COVID conditions 香叶乙酸钠在covid - 19后患者中的应用新进展
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-1-33-38
Z. Shugushev, A. A. Akulova
The emergence of the COVID-19 infection associated with multisystem disorders, long-term-complications (post-COVID conditions), low productivity and reduced quality of life, the lack of a unified treatment resulted to the search of novel agents and expansion of indication for use of pre-existing medications. Escine is an active ingredient of Aesculus hippocastanum (horse chestnut) which is well-known in the phlebological pharmaceutical market. This paper reviews recent pharmacological and clinical data on anti-edematous, anti-inflammatory, and antioxidant effects of sodium escinate in post-COVID conditions. The anti-inflammatory and antiviral effects of sodium escinate involve inhibiting the secretion of proinflammatory cytokines (including tumor necrosis factor a and interleukin 1β) by LPS-induced RAW264.7 macrophages. In Russia, escine is a component of a combined formulation based on horse chestnut seed extract and thiamine (vitamin B1). Given efficacy of sodium escinate (based on the results of in vitro and in vivo experimental studies) and its antiviral and anti-inflammatory properties, this agent can be prescribed for the COVID-19 complications. KEYWORDS: sodium escinate, post-COVID conditions, anti-inflammatory effects, phlebological agent, SARS-CoV-2. FOR CITATION: Shugushev Z.Kh., Akulova A.A. New look on the use of sodium escinate in patients with post-COVID conditions. Russian Medical Inquiry. 2022;6(1):33–38 (in Russ.). DOI: 10.32364/2587-6821-2022-6-1-33-38.
COVID-19感染的出现与多系统疾病、长期并发症(COVID-19后病症)、生产力低下和生活质量下降以及缺乏统一的治疗方法相关,导致寻找新的药物和扩大已有药物的适应症。七叶树碱是七叶树(七叶树)的一种有效成分,在血液药物市场上很有名。本文综述了近年来在covid - 19后条件下,肉桂酸钠的抗水肿、抗炎和抗氧化作用的药理和临床数据。肉桂酸钠的抗炎和抗病毒作用涉及抑制lps诱导的RAW264.7巨噬细胞分泌促炎细胞因子(包括肿瘤坏死因子a和白细胞介素1β)。在俄罗斯,叶香素是一种以七叶树籽提取物和硫胺素(维生素B1)为基础的组合配方的成分。鉴于肉桂酸钠的疗效(基于体外和体内实验研究结果)及其抗病毒和抗炎特性,该药物可用于治疗COVID-19并发症。关键词:肉桂酸钠、新冠肺炎后情况、抗炎作用、静脉制剂、SARS-CoV-2引用本文:Shugushev Z.Kh。香叶乙酸钠在covid - 19后患者中的应用新进展。俄罗斯医学调查。2022;6(1):33-38(俄文)。DOI: 10.32364 / 2587-6821-2022-6-1-33-38。
{"title":"New look on the use of sodium escinate in patients with post-COVID conditions","authors":"Z. Shugushev, A. A. Akulova","doi":"10.32364/2587-6821-2022-6-1-33-38","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-1-33-38","url":null,"abstract":"The emergence of the COVID-19 infection associated with multisystem disorders, long-term-complications (post-COVID conditions), low productivity and reduced quality of life, the lack of a unified treatment resulted to the search of novel agents and expansion of indication for use of pre-existing medications. Escine is an active ingredient of Aesculus hippocastanum (horse chestnut) which is well-known in the phlebological pharmaceutical market. This paper reviews recent pharmacological and clinical data on anti-edematous, anti-inflammatory, and antioxidant effects of sodium escinate in post-COVID conditions. The anti-inflammatory and antiviral effects of sodium escinate involve inhibiting the secretion of proinflammatory cytokines (including tumor necrosis factor a and interleukin 1β) by LPS-induced RAW264.7 macrophages. In Russia, escine is a component of a combined formulation based on horse chestnut seed extract and thiamine (vitamin B1). Given efficacy of sodium escinate (based on the results of in vitro and in vivo experimental studies) and its antiviral and anti-inflammatory properties, this agent can be prescribed for the COVID-19 complications. KEYWORDS: sodium escinate, post-COVID conditions, anti-inflammatory effects, phlebological agent, SARS-CoV-2. FOR CITATION: Shugushev Z.Kh., Akulova A.A. New look on the use of sodium escinate in patients with post-COVID conditions. Russian Medical Inquiry. 2022;6(1):33–38 (in Russ.). DOI: 10.32364/2587-6821-2022-6-1-33-38.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"206 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76202622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smart addition is multiplication: a review concerning combined use of hyaluronic acid and polynucleotides for intra-articular administration in osteoarthritis 聪明的增加是倍增:关于透明质酸和多核苷酸联合应用于骨关节炎关节内给药的综述
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-4-182-186
I. S. Svintsitskaya, K. Volkov
The article presents an overview of modern methods to the treatment of osteoarthritis (OA). It is focused on intra-articular injections of hyaluronic acid and polynucleotides (PNs) of natural origin. Hyaluronic acid is a natural component of connective tissue that has the ability to restore the viscoelastic properties of synovial fluid. Besides, it also has anti-apoptotic, anti-inflammatory, anti-angiogenic and antifibrotic characteristics. PNs are natural macromolecules derived from DNA. They have trophic activity and promote cell growth and collagen production, as has been shown in preclinical and clinical studies concerning cartilage regeneration. When injected into the joint cavity, PNs are subjected to enzymatic cleavage with the release of nucleosides, nucleotides and nitrogenous bases, thereby, providing long-term moisturizing and viscoelastic properties of synovial fluid. The efficacy of a combination of hyaluronic acid preparations with PNs for intra-articular administration for the treatment of knee OA has been studied. It has been established that the combined therapy with PNs and hyaluronic acid leads to the development of a more persistent therapeutic effect for 2 years after the treatment course versus with hyaluronic acid monotherapy. KEYWORDS: osteoarthritis, synovial fluid, viscoelastic properties, synovial fluid substitute, intra-articular injections, hyaluronic acid, polynucleotides FOR CITATION: Svintsitskaya I.S., Volkov K.Yu. Smart addition is multiplication: a review concerning combined use of hyaluronic acid and polynucleotides for intra-articular administration in osteoarthritis. Russian Medical Inquiry. 2022;6(4):182–186 (in Russ.). DOI: 10.32364/2587-6821-2022-6-4-182-186
本文概述了治疗骨关节炎(OA)的现代方法。它的重点是关节内注射透明质酸和天然多核苷酸(PNs)。透明质酸是结缔组织的天然成分,具有恢复滑液粘弹性的能力。此外,还具有抗凋亡、抗炎、抗血管生成、抗纤维化等特点。pn是一种从DNA中提取的天然大分子。它们具有营养活性,促进细胞生长和胶原蛋白的产生,这已经在有关软骨再生的临床前和临床研究中得到证实。当注入关节腔时,PNs受到酶促裂解,释放核苷、核苷酸和含氮碱基,从而提供滑膜液的长期保湿和粘弹性特性。已经研究了透明质酸制剂与PNs联合用于关节内给药治疗膝关节OA的疗效。与玻尿酸单一疗法相比,PNs和透明质酸联合疗法在治疗后2年的治疗效果更持久。关键词:骨关节炎,滑液,粘弹性,滑液替代物,关节内注射,透明质酸,多核苷酸。聪明的增加是倍增:关于透明质酸和多核苷酸联合应用于骨关节炎关节内给药的综述。俄罗斯医学调查。2022;6(4):182-186(俄文)。DOI: 10.32364 / 2587-6821-2022-6-4-182-186
{"title":"Smart addition is multiplication: a review concerning combined use of hyaluronic acid and polynucleotides for intra-articular administration in osteoarthritis","authors":"I. S. Svintsitskaya, K. Volkov","doi":"10.32364/2587-6821-2022-6-4-182-186","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-4-182-186","url":null,"abstract":"The article presents an overview of modern methods to the treatment of osteoarthritis (OA). It is focused on intra-articular injections of hyaluronic acid and polynucleotides (PNs) of natural origin. Hyaluronic acid is a natural component of connective tissue that has the ability to restore the viscoelastic properties of synovial fluid. Besides, it also has anti-apoptotic, anti-inflammatory, anti-angiogenic and antifibrotic characteristics. PNs are natural macromolecules derived from DNA. They have trophic activity and promote cell growth and collagen production, as has been shown in preclinical and clinical studies concerning cartilage regeneration. When injected into the joint cavity, PNs are subjected to enzymatic cleavage with the release of nucleosides, nucleotides and nitrogenous bases, thereby, providing long-term moisturizing and viscoelastic properties of synovial fluid. The efficacy of a combination of hyaluronic acid preparations with PNs for intra-articular administration for the treatment of knee OA has been studied. It has been established that the combined therapy with PNs and hyaluronic acid leads to the development of a more persistent therapeutic effect for 2 years after the treatment course versus with hyaluronic acid monotherapy. KEYWORDS: osteoarthritis, synovial fluid, viscoelastic properties, synovial fluid substitute, intra-articular injections, hyaluronic acid, polynucleotides FOR CITATION: Svintsitskaya I.S., Volkov K.Yu. Smart addition is multiplication: a review concerning combined use of hyaluronic acid and polynucleotides for intra-articular administration in osteoarthritis. Russian Medical Inquiry. 2022;6(4):182–186 (in Russ.). DOI: 10.32364/2587-6821-2022-6-4-182-186","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74265744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of IL-1β, TNF-α, IL-10, IL-17, and IL-4 gene polymorphisms in the pathogenesis of chronic rhinosinusitis with nasal polyps
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-2-57-61
N. Baranova, B. Molotilov, L. Ashchina, N. Shkurova
Background: chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial disease, those mechanisms are not fully understood. A significant role of cytokines, e.g., interleukin (IL)-1β, tumor necrosis factor (TNF) α, IL-10, IL-17А, IL-4, and their genes, in the pathogenesis and predisposition to CRSwNP and treatment efficacy is established. Aim: to investigate IL-1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17(G-197A), and IL-4 (С-589Т) gene polymorphisms and their role in CRSwNP pathogenesis. Patients and Methods: this open-label, prospective, randomized study enrolled 100 patients with CRSwNP. The control group included 72 healthy volunteers. DNA was isolated from the whole venous blood. IL-1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17 (G-197A), and IL-4 (С-589Т) gene polymorphisms were assessed by the real-time polymerase chain reaction (PCR). Results: the analysis of IL-4 (С-589Т) gene polymorphism has demonstrated that 589С/С genotype is more common in CRSwNP patients compared to the controls (р=0.021, odds ratio/OR=1.248 [0.449–3.465]). The analysis of IL-10 (G-1082A) gene polymorphism has demonstrated that 1082А/A genotype is more common in CRSwNP patients compared to the controls (p=0.043, OR=1.027 [0.374–2.830]). The analysis of IL-17 (G-197A) gene polymorphism has demonstrated that 197A/А genotype is more common in CRSwNP patients than in the controls (p=0.046, OR=7.250 [0.863–2.532]). The analysis of TNF-α (G-308A) gene polymorphism has demonstrated that 308 G/G genotype is more common in CRSwNP patients compared to the controls (p=0.045, OR=1.789 [0.892–4.776]). Conclusion: the most relevant predictors of the increased risk of CRSwNP are 589С/С genotype of IL-4 gene, 1082А/A genotype of IL-10 gene, 197A/А genotype of IL-17 gene, and 308 G/G genotype of TNF-α gene. The analysis of essential cytokine gene polymorphisms, i.e., IL- 1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17 (G-197A), and IL-4 (С-589Т), allows assessing genetic predisposition to CRSwNP. This technique is an important tool for predicting treatment efficacy. KEYWORDS: chronic rhinosinusitis with nasal polyps, cytokines, genotype, gene polymorphism, pathogenic mechanisms. FOR CITATION: Baranova N.I., Molotilov B.A., Ashchina L.A., Shkurova N.A. Role of IL-1β, TNF-α, IL-10, IL-17, and IL-4 gene polymorphisms in the pathogenesis of chronic rhinosinusitis with nasal polyps. Russian Medical Inquiry. 2022;6(2):57–61 (in Russ.). DOI: 10.32364/2587-6821-2022-6-2-57-61.
背景:慢性鼻窦炎伴鼻息肉(CRSwNP)是一种多因素疾病,其发病机制尚不完全清楚。证实了白细胞介素(IL)-1β、肿瘤坏死因子(TNF) α、IL-10、IL-17А、IL-4等细胞因子及其基因在CRSwNP发病、易感性及治疗效果中的重要作用。目的:探讨IL-1β (Т-31С)、TNF-α (G-308A)、IL-10 (G-1082A)、IL-17(G-197A)、IL-4 (С-589Т)基因多态性及其在CRSwNP发病机制中的作用。患者和方法:这项开放标签、前瞻性、随机研究纳入了100例CRSwNP患者。对照组包括72名健康志愿者。从整个静脉血中分离出DNA。实时聚合酶链反应(PCR)检测IL-1β (Т-31С)、TNF-α (G-308A)、IL-10 (G-1082A)、IL-17 (G-197A)和IL-4 (С-589Т)基因多态性。结果:IL-4 (С-589Т)基因多态性分析显示,与对照组相比,589С/С基因型在CRSwNP患者中更为常见(r =0.021,比值比/OR=1.248[0.449-3.465])。IL-10 (G-1082A)基因多态性分析表明,与对照组相比,1082А/A基因型在CRSwNP患者中更为常见(p=0.043, OR=1.027[0.374-2.830])。IL-17 (G-197A)基因多态性分析表明,197A/А基因型在CRSwNP患者中比对照组更常见(p=0.046, OR=7.250[0.863-2.532])。TNF-α (G- 308a)基因多态性分析表明,308 G/G基因型在CRSwNP患者中比对照组更常见(p=0.045, OR=1.789[0.892-4.776])。结论:IL-4基因589С/С基因型、IL-10基因1082А/A基因型、IL-17基因197A/А基因型、TNF-α基因308 G/G基因型是CRSwNP风险增加的最相关预测因子。必需细胞因子基因多态性的分析,即IL- 1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17 (G-197A)和IL-4 (С-589Т),可以评估CRSwNP的遗传易感性。该技术是预测治疗效果的重要工具。关键词:慢性鼻窦炎伴鼻息肉,细胞因子,基因型,基因多态性,致病机制。引用本文:Baranova N.I., Molotilov B.A, Ashchina L.A, Shkurova N.A. IL-1β、TNF-α、IL-10、IL-17和IL-4基因多态性在慢性鼻窦炎伴鼻息肉发病中的作用。俄罗斯医学调查。2022;6(2):57-61(俄文)。DOI: 10.32364 / 2587-6821-2022-6-2-57-61。
{"title":"Role of IL-1β, TNF-α, IL-10, IL-17, and IL-4 gene polymorphisms in the pathogenesis of chronic rhinosinusitis with nasal polyps","authors":"N. Baranova, B. Molotilov, L. Ashchina, N. Shkurova","doi":"10.32364/2587-6821-2022-6-2-57-61","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-2-57-61","url":null,"abstract":"Background: chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial disease, those mechanisms are not fully understood. A significant role of cytokines, e.g., interleukin (IL)-1β, tumor necrosis factor (TNF) α, IL-10, IL-17А, IL-4, and their genes, in the pathogenesis and predisposition to CRSwNP and treatment efficacy is established. Aim: to investigate IL-1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17(G-197A), and IL-4 (С-589Т) gene polymorphisms and their role in CRSwNP pathogenesis. Patients and Methods: this open-label, prospective, randomized study enrolled 100 patients with CRSwNP. The control group included 72 healthy volunteers. DNA was isolated from the whole venous blood. IL-1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17 (G-197A), and IL-4 (С-589Т) gene polymorphisms were assessed by the real-time polymerase chain reaction (PCR). Results: the analysis of IL-4 (С-589Т) gene polymorphism has demonstrated that 589С/С genotype is more common in CRSwNP patients compared to the controls (р=0.021, odds ratio/OR=1.248 [0.449–3.465]). The analysis of IL-10 (G-1082A) gene polymorphism has demonstrated that 1082А/A genotype is more common in CRSwNP patients compared to the controls (p=0.043, OR=1.027 [0.374–2.830]). The analysis of IL-17 (G-197A) gene polymorphism has demonstrated that 197A/А genotype is more common in CRSwNP patients than in the controls (p=0.046, OR=7.250 [0.863–2.532]). The analysis of TNF-α (G-308A) gene polymorphism has demonstrated that 308 G/G genotype is more common in CRSwNP patients compared to the controls (p=0.045, OR=1.789 [0.892–4.776]). Conclusion: the most relevant predictors of the increased risk of CRSwNP are 589С/С genotype of IL-4 gene, 1082А/A genotype of IL-10 gene, 197A/А genotype of IL-17 gene, and 308 G/G genotype of TNF-α gene. The analysis of essential cytokine gene polymorphisms, i.e., IL- 1β (Т-31С), TNF-α (G-308A), IL-10 (G-1082A), IL-17 (G-197A), and IL-4 (С-589Т), allows assessing genetic predisposition to CRSwNP. This technique is an important tool for predicting treatment efficacy. KEYWORDS: chronic rhinosinusitis with nasal polyps, cytokines, genotype, gene polymorphism, pathogenic mechanisms. FOR CITATION: Baranova N.I., Molotilov B.A., Ashchina L.A., Shkurova N.A. Role of IL-1β, TNF-α, IL-10, IL-17, and IL-4 gene polymorphisms in the pathogenesis of chronic rhinosinusitis with nasal polyps. Russian Medical Inquiry. 2022;6(2):57–61 (in Russ.). DOI: 10.32364/2587-6821-2022-6-2-57-61.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75196742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbiota pattern in Crohn’s disease depending on the presence of small intestinal bacterial overgrowth 克罗恩病的微生物群模式取决于小肠细菌过度生长的存在
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-5-221-226
Y. Kulygina, M. Osipenko, T. Alikina
Aim: to evaluate microbiota in Crohn’s disease depending on the presence/absence of small intestinal bacterial overgrowth (SIBO). Patients and Methods: thirteen patients with Crohn’s disease affecting the small intestine were enrolled. Gut microbiota composition was analyzed using the 16S rRNA gene sequencing. 16S rDNA clone libraries were generated similarly. All patients underwent lactulose hydrogen breath test using Gastroplus+ monitor to establish SIBO. A positive lactulose hydrogen breath test indicated SIBO. Results: hydrogen breath test revealed SIBO in 8 patients with Crohn’s disease affecting the small intestine (61.5%). All these patients were women (mean age 40.5 [34.5; 51.2] years). In 5 patients (mean age 32.4 [28.7; 36.5] years), SIBO was not detected. The metagenome analysis of intestinal bacteria identified certain significant differences in microbiota composition in patients with Crohn’s disease depending on the presence/absence of SIBO. In Crohn’s disease affecting the small intestine, SIBO was associated with greater occurrence of Chryseobacterium spp. (р=0.045), Klebsiella spp. (р=0.045), Phocaecola operational taxonomic unit (OTU) (р=0.045), Enterobacteriaceae OTU (р=0.045), Pasteurellales. (р=0.031), Peptoniphilaceae (р=0,023), Solobacterium spp. (р=0.002), Haemophilus spp. (р=0.031), Lachnospiracea OTU (р=0.045), and Bifidobacterium spp. (р=0.019). Conclusions: a taxonomic shift with the reduction of Firmicutes and Bifidobacterium and increase of Proteobacteria (i.e., Klebsiella spp. and Enterobacteriaceae OTU) was revealed in patients with Crohn’s disease and SIBO. KEYWORDS: inflammatory bowel disease, Crohn’s disease, microbiota, small intestinal bacterial overgrowth, hydrogen respiratory test. FOR CITATION: Kulygina Yu.A., Osipenko M.F., Alikina T.Yu. Microbiota pattern in Crohn’s disease depending on the presence ofsmall intestinal bacterial overgrowth. Russian Medical Inquiry. 2022;6(5):221–226 (in Russ.). DOI: 10.32364/2587-6821-2022-6-5-221-226.
目的:通过小肠细菌过度生长(SIBO)的存在/不存在来评估克罗恩病的微生物群。患者和方法:纳入13例影响小肠的克罗恩病患者。采用16S rRNA基因测序分析肠道菌群组成。16S rDNA克隆文库以类似方式生成。所有患者均采用Gastroplus+监测仪进行乳果糖氢呼气试验,建立SIBO。乳果糖氢呼气试验阳性表明SIBO。结果:8例克罗恩病(Crohn 's disease)患者氢呼气试验显示SIBO(61.5%)。所有患者均为女性(平均年龄40.5岁[34.5;51.2年)。5例患者(平均年龄32.4岁;36.5]年),未检出SIBO。肠道细菌宏基因组分析发现,克罗恩病患者的微生物群组成存在一定的显著差异,这取决于SIBO的存在/缺失。在影响小肠的克罗恩病中,SIBO与较高的黄杆菌(0.045)、克雷伯氏菌(0.045)、Phocaecola操作分类单位(OTU)(0.045)、肠杆菌科OTU(0.045)、巴氏杆菌(pasteurelales)的发生率相关。(r =0.031),胃杆菌科(r = 0.023), Solobacterium spp (r =0.002), Haemophilus spp (r =0.031), Lachnospiracea OTU (r =0.045), Bifidobacterium spp (r =0.019)。结论:克罗恩病和SIBO患者的分类学发生转变,厚壁菌门和双歧杆菌减少,变形菌门(即克雷伯氏菌和肠杆菌科OTU)增加。关键词:炎症性肠病,克罗恩病,微生物群,小肠细菌过度生长,氢呼吸试验引用本文:Kulygina Yu.A。,奥西潘科m.f., Alikina T.Yu。克罗恩病的微生物群模式取决于小肠细菌过度生长的存在。俄罗斯医学调查。2022;6(5):221-226(俄文)。DOI: 10.32364 / 2587-6821-2022-6-5-221-226。
{"title":"Microbiota pattern in Crohn’s disease depending on the presence of small intestinal bacterial overgrowth","authors":"Y. Kulygina, M. Osipenko, T. Alikina","doi":"10.32364/2587-6821-2022-6-5-221-226","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-5-221-226","url":null,"abstract":"Aim: to evaluate microbiota in Crohn’s disease depending on the presence/absence of small intestinal bacterial overgrowth (SIBO). Patients and Methods: thirteen patients with Crohn’s disease affecting the small intestine were enrolled. Gut microbiota composition was analyzed using the 16S rRNA gene sequencing. 16S rDNA clone libraries were generated similarly. All patients underwent lactulose hydrogen breath test using Gastroplus+ monitor to establish SIBO. A positive lactulose hydrogen breath test indicated SIBO. Results: hydrogen breath test revealed SIBO in 8 patients with Crohn’s disease affecting the small intestine (61.5%). All these patients were women (mean age 40.5 [34.5; 51.2] years). In 5 patients (mean age 32.4 [28.7; 36.5] years), SIBO was not detected. The metagenome analysis of intestinal bacteria identified certain significant differences in microbiota composition in patients with Crohn’s disease depending on the presence/absence of SIBO. In Crohn’s disease affecting the small intestine, SIBO was associated with greater occurrence of Chryseobacterium spp. (р=0.045), Klebsiella spp. (р=0.045), Phocaecola operational taxonomic unit (OTU) (р=0.045), Enterobacteriaceae OTU (р=0.045), Pasteurellales. (р=0.031), Peptoniphilaceae (р=0,023), Solobacterium spp. (р=0.002), Haemophilus spp. (р=0.031), Lachnospiracea OTU (р=0.045), and Bifidobacterium spp. (р=0.019). Conclusions: a taxonomic shift with the reduction of Firmicutes and Bifidobacterium and increase of Proteobacteria (i.e., Klebsiella spp. and Enterobacteriaceae OTU) was revealed in patients with Crohn’s disease and SIBO. KEYWORDS: inflammatory bowel disease, Crohn’s disease, microbiota, small intestinal bacterial overgrowth, hydrogen respiratory test. FOR CITATION: Kulygina Yu.A., Osipenko M.F., Alikina T.Yu. Microbiota pattern in Crohn’s disease depending on the presence ofsmall intestinal bacterial overgrowth. Russian Medical Inquiry. 2022;6(5):221–226 (in Russ.). DOI: 10.32364/2587-6821-2022-6-5-221-226.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"49 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80820814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute respiratory infections: current clinical recommendations. Focus on the issues of phytotherapy 急性呼吸道感染:目前的临床建议。关注植物疗法的问题
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-7-376-386
V. Belov, E. P. Karpova, A. Zaplatnikov, A. Girina, I. V. Lepiseva, V. I. Svintsitskaya
Since January 1, 2022, the provision of medical care in most common infectious and inflammatory human diseases as acute respiratory infections (ARI) has already been carried out according to the relevant clinical recommendations (CRs) approved by the Ministry of Health of the Russian Federation. Due to the fact that ARI in the vast majority of cases are caused by viruses, much attention is paid to rational antibiotic therapy and the use of phytopreparations as a reasonable alternative to down the growth rate of antibiotic resistance. The article highlights the therapeutic possibilities of modern phytotherapy in the treatment of children with the most common manifestations of ARI (rhinosinusitis, tonsillopharyngitis, bronchitis) based on the CRs. A brief description of etiological factors, clinical symptoms, and diagnostic characteristics is given. The article also presents the results of in vitro and in vivo work, pathogenetically substantiating the expediency of using phytopreparations in ARI, as well as clinical research data confirming their efficacy and safety, including in children. It is particularly noted that following the CRs concerning patient management with ARI will reduce the frequency of unjustified prescribing of antibacterial drugs and polypragmasia in general, as well as improve the medical care quality. KEYWORDS: acute respiratory infections, rhinosinusitis, tonsillopharyngitis, bronchitis, clinical recommendations, phytotherapy, evidence- based medicine. FOR CITATION: Belov V.A., Karpova E.P., Zaplatnikov A.L. et al. Acute respiratory infections: current clinical recommendations. Focus on the issues of phytotherapy. Russian Medical Inquiry. 2022;6(7):376–386 (in Russ.). DOI: 10.32364/2587-6821-2022-6-7-376-386.
自2022年1月1日起,已根据俄罗斯联邦卫生部批准的相关临床建议,为急性呼吸道感染等最常见的传染性和炎症性人类疾病提供医疗服务。由于绝大多数ARI病例是由病毒引起的,因此合理的抗生素治疗和使用植物修复作为降低抗生素耐药性增长速度的合理替代方案受到了广泛关注。文章强调了现代植物疗法在治疗ARI(鼻鼻窦炎、扁桃体咽炎、支气管炎)最常见表现的儿童中的治疗可能性。对其病因、临床症状和诊断特点作了简要的描述。本文还介绍了体外和体内工作的结果,病理证实了在ARI中使用植物修复剂的便捷性,以及临床研究数据证实其有效性和安全性,包括在儿童中。特别值得注意的是,遵循关于ARI患者管理的cr将减少抗菌药物不合理处方的频率和总体上的多语用症,并提高医疗质量。关键词:急性呼吸道感染,鼻窦炎,扁桃体咽炎,支气管炎,临床推荐,植物疗法,循证医学。引用本文:Belov v.a., Karpova e.p., Zaplatnikov A.L.等。急性呼吸道感染:目前的临床建议。关注植物疗法的问题。俄罗斯医学调查。2022;6(7):376-386(俄文)。DOI: 10.32364 / 2587-6821-2022-6-7-376-386。
{"title":"Acute respiratory infections: current clinical recommendations. Focus on the issues of phytotherapy","authors":"V. Belov, E. P. Karpova, A. Zaplatnikov, A. Girina, I. V. Lepiseva, V. I. Svintsitskaya","doi":"10.32364/2587-6821-2022-6-7-376-386","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-7-376-386","url":null,"abstract":"Since January 1, 2022, the provision of medical care in most common infectious and inflammatory human diseases as acute respiratory infections (ARI) has already been carried out according to the relevant clinical recommendations (CRs) approved by the Ministry of Health of the Russian Federation. Due to the fact that ARI in the vast majority of cases are caused by viruses, much attention is paid to rational antibiotic therapy and the use of phytopreparations as a reasonable alternative to down the growth rate of antibiotic resistance. The article highlights the therapeutic possibilities of modern phytotherapy in the treatment of children with the most common manifestations of ARI (rhinosinusitis, tonsillopharyngitis, bronchitis) based on the CRs. A brief description of etiological factors, clinical symptoms, and diagnostic characteristics is given. The article also presents the results of in vitro and in vivo work, pathogenetically substantiating the expediency of using phytopreparations in ARI, as well as clinical research data confirming their efficacy and safety, including in children. It is particularly noted that following the CRs concerning patient management with ARI will reduce the frequency of unjustified prescribing of antibacterial drugs and polypragmasia in general, as well as improve the medical care quality. KEYWORDS: acute respiratory infections, rhinosinusitis, tonsillopharyngitis, bronchitis, clinical recommendations, phytotherapy, evidence- based medicine. FOR CITATION: Belov V.A., Karpova E.P., Zaplatnikov A.L. et al. Acute respiratory infections: current clinical recommendations. Focus on the issues of phytotherapy. Russian Medical Inquiry. 2022;6(7):376–386 (in Russ.). DOI: 10.32364/2587-6821-2022-6-7-376-386.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80255386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Drug-coated balloon angioplasty in peripheral arterial disease 外周动脉疾病的药物包被球囊血管成形术
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-4-177-181
S. Papoyan, A. A. Shchegolev, D. Gromov, K. Asaturyan
The prevalence of peripheral arterial disease requires the search for an optimal solution for preserving blood flow by using devices of various modifications. Drug-coated balloons are widely used in the surgical treatment of peripheral arterial disease. The article aims at the summarization of the study results on the efficacy and safety of the various drug-coated balloons, in particular, with paclitaxel, in the treatment of steno-occlusive lesions in the peripheral arterial disease. Comparing the study results is fraught with certain difficulties, given the differences in the study endpoints, the demographic characteristics of patients and the lesion patterns. Nevertheless, the study results of percutaneous transluminal angioplasty (PTA) with drug-eluting ballons on the femoropopliteal segment are superior to the results obtained using conventional PTA and other endovascular interventions in the same vascular bed. PTA with drug-eluting balloons has a Class 1 recommendation in accordance with the issued recommendations of the SCAI (Society for Cardiovascular Angiography and Interventions). However, conducting PTA with paclitaxel-eluting balloons requires further determination of the possibilities of its use. KEYWORDS: drug-coated balloons, paclitaxel, percutaneous transluminal angioplasty, angioplasty, atherosclerosis, peripheral arterial disease. FOR CITATION: Papoyan S.A., Shchegolev A.A., Gromov D.G., Asaturyan K.S. Drug-coated balloon angioplasty in peripheral arterial disease. Russian Medical Inquiry. 2022;6(4):177–181 (in Russ.). DOI: 10.32364/2587-6821-2022-6-4-177-181.
外周动脉疾病的流行需要通过使用各种修改的设备来寻找保持血液流动的最佳解决方案。药物包被球囊广泛应用于外周动脉疾病的外科治疗。本文旨在总结各种药物包被球囊,特别是紫杉醇包被球囊治疗外周动脉狭窄闭塞病变的有效性和安全性的研究结果。考虑到研究终点、患者人口统计学特征和病变模式的差异,比较研究结果充满了一定的困难。然而,经皮腔内血管成形术(PTA)在股腘段药物洗脱球囊的研究结果优于传统PTA和其他血管内干预在同一血管床上获得的结果。根据SCAI(心血管血管造影和干预学会)发布的建议,药物洗脱气球的PTA具有1级推荐。然而,用紫杉醇洗脱气球进行PTA需要进一步确定其使用的可能性。关键词:药物包被气球、紫杉醇、经皮腔内血管成形术、血管成形术、动脉粥样硬化、外周动脉疾病。引用本文:Papoyan S.A, Shchegolev A.A, Gromov d.g., Asaturyan K.S.外周动脉疾病的药物包被球囊血管成形术。俄罗斯医学调查。2022;6(4):177-181(俄文)。DOI: 10.32364 / 2587-6821-2022-6-4-177-181。
{"title":"Drug-coated balloon angioplasty in peripheral arterial disease","authors":"S. Papoyan, A. A. Shchegolev, D. Gromov, K. Asaturyan","doi":"10.32364/2587-6821-2022-6-4-177-181","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-4-177-181","url":null,"abstract":"The prevalence of peripheral arterial disease requires the search for an optimal solution for preserving blood flow by using devices of various modifications. Drug-coated balloons are widely used in the surgical treatment of peripheral arterial disease. The article aims at the summarization of the study results on the efficacy and safety of the various drug-coated balloons, in particular, with paclitaxel, in the treatment of steno-occlusive lesions in the peripheral arterial disease. Comparing the study results is fraught with certain difficulties, given the differences in the study endpoints, the demographic characteristics of patients and the lesion patterns. Nevertheless, the study results of percutaneous transluminal angioplasty (PTA) with drug-eluting ballons on the femoropopliteal segment are superior to the results obtained using conventional PTA and other endovascular interventions in the same vascular bed. PTA with drug-eluting balloons has a Class 1 recommendation in accordance with the issued recommendations of the SCAI (Society for Cardiovascular Angiography and Interventions). However, conducting PTA with paclitaxel-eluting balloons requires further determination of the possibilities of its use. KEYWORDS: drug-coated balloons, paclitaxel, percutaneous transluminal angioplasty, angioplasty, atherosclerosis, peripheral arterial disease. FOR CITATION: Papoyan S.A., Shchegolev A.A., Gromov D.G., Asaturyan K.S. Drug-coated balloon angioplasty in peripheral arterial disease. Russian Medical Inquiry. 2022;6(4):177–181 (in Russ.). DOI: 10.32364/2587-6821-2022-6-4-177-181.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"56 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91484789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical characteristics of the novel coronavirus infection in HIV-positive patient with underlying chronic hepatitis C hiv阳性合并慢性丙型肝炎患者新型冠状病毒感染的临床特征
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-11-656-658
I.A. Matyazh, E. V. Ivakhnenko, A.V. Grokhotova
In view of the global pandemic caused by the novel coronavirus disease, HIV-infected people fall into a higher risk group, as they have a weakened immune system and underlying health conditions. Currently, much research focuses on the clinical characteristics of the coronavirus infection in various population groups with comorbidities, including HIV-positive patients. The article describes the clinical course of the novel coronavirus diseases in a male patient, 44 years of age, newly diagnosed with HIV at the time of hospitalization, who also had chronic hepatitis C with low specific enzyme levels. The chest CT scans demonstrated multiple polygonal sites of increased attenuation of the lung parenchyma (ground glass opacities) in segments S2, S3, S4, S5, S6–S10 of the right lung and in S3, S6–S10 segments of the left lung; these changes were more pronounced in the right lung. Most of the sites were detected in the subpleural region and close to the lung roots. The absence of highly active antiretroviral therapy resulted in a severe immunosuppression — during patient’s stay at the hospital the number of leucocytes decreased from 3.62×109/l to 2.54×109/l. However, in the entire period of illness, his condition remained stable (moderate severity), and no complications were reported. KEYWORDS: HIV-infection, chronic hepatitis C, COVID-19, novel coronavirus infection. FOR CITATION: Matyazh I.A., Ivakhnenko E.V., Grokhotova A.V. Clinical characteristics of the novel coronavirus infection in HIV- positive patient with underlying chronic hepatitis C. Russian Medical Inquiry. 2022;6(11):656–658 (in Russ.). DOI: 10.32364/2587- 6821-2022-6-11-656-658.
鉴于新型冠状病毒病引起的全球大流行,艾滋病毒感染者由于免疫系统较弱和潜在的健康状况,属于高风险人群。目前,很多研究都集中在包括hiv阳性患者在内的不同人群的合并症中冠状病毒感染的临床特征。本文描述了一名44岁男性患者的临床病程,住院时新诊断为HIV,同时患有慢性丙型肝炎,特异性酶水平低。胸部CT示右肺S2、S3、S4、S5、S6-S10段及左肺S3、S6-S10段多多边形肺实质衰减增强(磨玻璃影);这些变化在右肺更为明显。大多数部位位于胸膜下区域和靠近肺根。缺乏高效抗逆转录病毒治疗导致严重的免疫抑制——在病人住院期间,白细胞数量从3.62×109/l下降到2.54×109/l。然而,在整个疾病期间,他的病情保持稳定(中度严重),无并发症报告。关键词:hiv感染;慢性丙型肝炎;COVID-19;引用本文:Matyazh i.a., Ivakhnenko e.v., Grokhotova A.V.。HIV阳性慢性丙型肝炎患者新型冠状病毒感染的临床特征。俄罗斯医学调查,2022;6(11):656-658。Doi: 10.32364/2587- 6821-2022-6-11-656-658。
{"title":"Clinical characteristics of the novel coronavirus infection in HIV-positive patient with underlying chronic hepatitis C","authors":"I.A. Matyazh, E. V. Ivakhnenko, A.V. Grokhotova","doi":"10.32364/2587-6821-2022-6-11-656-658","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-11-656-658","url":null,"abstract":"In view of the global pandemic caused by the novel coronavirus disease, HIV-infected people fall into a higher risk group, as they have a weakened immune system and underlying health conditions. Currently, much research focuses on the clinical characteristics of the coronavirus infection in various population groups with comorbidities, including HIV-positive patients. The article describes the clinical course of the novel coronavirus diseases in a male patient, 44 years of age, newly diagnosed with HIV at the time of hospitalization, who also had chronic hepatitis C with low specific enzyme levels. The chest CT scans demonstrated multiple polygonal sites of increased attenuation of the lung parenchyma (ground glass opacities) in segments S2, S3, S4, S5, S6–S10 of the right lung and in S3, S6–S10 segments of the left lung; these changes were more pronounced in the right lung. Most of the sites were detected in the subpleural region and close to the lung roots. The absence of highly active antiretroviral therapy resulted in a severe immunosuppression — during patient’s stay at the hospital the number of leucocytes decreased from 3.62×109/l to 2.54×109/l. However, in the entire period of illness, his condition remained stable (moderate severity), and no complications were reported. KEYWORDS: HIV-infection, chronic hepatitis C, COVID-19, novel coronavirus infection. FOR CITATION: Matyazh I.A., Ivakhnenko E.V., Grokhotova A.V. Clinical characteristics of the novel coronavirus infection in HIV- positive patient with underlying chronic hepatitis C. Russian Medical Inquiry. 2022;6(11):656–658 (in Russ.). DOI: 10.32364/2587- 6821-2022-6-11-656-658.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90290737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of sarcopenia and carotid atherosclerosis in elderly male patients with knee osteoarthritis 老年男性膝骨关节炎患者肌肉减少症与颈动脉粥样硬化的关系
Pub Date : 2022-01-01 DOI: 10.32364/2587-6821-2022-6-3-120-125
L. Alekseeva, E. Taskina, T. Raskina, M. Letaeva, O. Malyshenko, M. Koroleva, Yu. V. Averkieva, I. I. Grigorieva
Aim: to evaluate the association of sarcopenia and carotid atherosclerosis in elderly male patients with knee osteoarthritis (OA). Materials and Methods: the study included 36 patients (mean age — 68.9 (66; 71) years) with an established diagnosis of grade II–III knee OA according to the Kellgren-Lawrence scale. Diagnosis of sarcopenia was conducted on the basis of the European Working Group on Sarcopenia in Older People (EWGSOP, 2010) recommendations with the determination of three parameters: muscle strength, muscle mass and muscle function. The severity of carotid atherosclerotic lesions was assessed by duplex color scanning with examination of the intima-media thickness (IMT), the presence of atherosclerotic plaques and the degree of aortic stenosis. Comparative analysis was performed in 3 groups: group 1 — 10 patients without sarcopenia, group 2— 12 patients with presarcopenia, and group 3 — 14 patients with sarcopenia. Results: IMT in group 3 with sarcopenia was statistically significantly (p=0.005) higher versus the same indicator in men without sarcopenia. The majority (23 (63.9%)) of the patients included in the study had carotid atherosclerotic lesions. The most severe carotid lesion with multiple atherosclerotic plaques and stenosis not less than 50% was significantly more commonly detected in patients with sarcopenia: 35.7% versus group 2 with presarcopenia (8.3%, p=0.015) and without sarcopenia (10.0%, p=0.013). According to the correlation analysis, a significant negative association was established between the severity of carotid atherosclerosis and the musculoskeletal index (r=-0.227, p=0.047). Conclusion: the association between carotid atherosclerosis and body composition disorders in men with knee OA allows discussing atherosclerosis and sarcopenia as two conditions with common pathogenetic mechanisms that potentially increase the risk of adverse outcomes. KEYWORDS: sarcopenia, presarcopenia, carotid atherosclerosis, osteoarthritis, elderly, male. FOR CITATION: Alekseeva L.I., Taskina E.A., Raskina T.A. et al. Association of sarcopenia and carotid atherosclerosis in elderly male patients with knee osteoarthritis. Russian Medical Inquiry. 2022;6(3):120–125 (in Russ.). DOI: 10.32364/2587-6821-2022-6-3-120-125.
目的:探讨老年男性膝关节骨性关节炎(OA)患者颈动脉粥样硬化与肌肉减少症的关系。材料与方法:研究纳入36例患者,平均年龄- 68.9岁(66岁;71岁),根据kelgren - lawrence量表确诊为II-III级膝关节炎。肌少症的诊断是根据欧洲老年人肌少症工作组(EWGSOP, 2010)的建议进行的,并确定了三个参数:肌肉力量、肌肉质量和肌肉功能。通过双彩色扫描检查颈动脉内膜-中膜厚度(IMT),动脉粥样硬化斑块的存在和主动脉狭窄程度来评估颈动脉粥样硬化病变的严重程度。比较分析3组:1 ~ 10例无肌少症患者,2 ~ 12例有肌少症患者,3 ~ 14例有肌少症患者。结果:肌少症3组IMT高于无肌少症3组,差异有统计学意义(p=0.005)。大多数(23例(63.9%))纳入研究的患者有颈动脉粥样硬化病变。伴有多发性动脉粥样硬化斑块和狭窄不少于50%的最严重颈动脉病变在肌少症患者中更为常见:35.7%,而肌少症前2组(8.3%,p=0.015)和无肌少症组(10.0%,p=0.013)。经相关分析,颈动脉粥样硬化严重程度与肌肉骨骼指数呈显著负相关(r=-0.227, p=0.047)。结论:男性膝关节OA患者颈动脉粥样硬化与体成分障碍之间的关系允许我们讨论动脉粥样硬化和肌肉减少症这两种具有共同发病机制的疾病,这两种疾病可能会增加不良结局的风险。关键词:肌肉减少症,肌肉减少症前期,颈动脉粥样硬化,骨关节炎,老年,男性。引文来源:Alekseeva l.i., Taskina e.a., Raskina T.A.等。老年男性膝骨关节炎患者肌肉减少症与颈动脉粥样硬化的关系。俄罗斯医学调查。2022;6(3):120-125(俄文)。DOI: 10.32364 / 2587-6821-2022-6-3-120-125。
{"title":"Association of sarcopenia and carotid atherosclerosis in elderly male patients with knee osteoarthritis","authors":"L. Alekseeva, E. Taskina, T. Raskina, M. Letaeva, O. Malyshenko, M. Koroleva, Yu. V. Averkieva, I. I. Grigorieva","doi":"10.32364/2587-6821-2022-6-3-120-125","DOIUrl":"https://doi.org/10.32364/2587-6821-2022-6-3-120-125","url":null,"abstract":"Aim: to evaluate the association of sarcopenia and carotid atherosclerosis in elderly male patients with knee osteoarthritis (OA). Materials and Methods: the study included 36 patients (mean age — 68.9 (66; 71) years) with an established diagnosis of grade II–III knee OA according to the Kellgren-Lawrence scale. Diagnosis of sarcopenia was conducted on the basis of the European Working Group on Sarcopenia in Older People (EWGSOP, 2010) recommendations with the determination of three parameters: muscle strength, muscle mass and muscle function. The severity of carotid atherosclerotic lesions was assessed by duplex color scanning with examination of the intima-media thickness (IMT), the presence of atherosclerotic plaques and the degree of aortic stenosis. Comparative analysis was performed in 3 groups: group 1 — 10 patients without sarcopenia, group 2— 12 patients with presarcopenia, and group 3 — 14 patients with sarcopenia. Results: IMT in group 3 with sarcopenia was statistically significantly (p=0.005) higher versus the same indicator in men without sarcopenia. The majority (23 (63.9%)) of the patients included in the study had carotid atherosclerotic lesions. The most severe carotid lesion with multiple atherosclerotic plaques and stenosis not less than 50% was significantly more commonly detected in patients with sarcopenia: 35.7% versus group 2 with presarcopenia (8.3%, p=0.015) and without sarcopenia (10.0%, p=0.013). According to the correlation analysis, a significant negative association was established between the severity of carotid atherosclerosis and the musculoskeletal index (r=-0.227, p=0.047). Conclusion: the association between carotid atherosclerosis and body composition disorders in men with knee OA allows discussing atherosclerosis and sarcopenia as two conditions with common pathogenetic mechanisms that potentially increase the risk of adverse outcomes. KEYWORDS: sarcopenia, presarcopenia, carotid atherosclerosis, osteoarthritis, elderly, male. FOR CITATION: Alekseeva L.I., Taskina E.A., Raskina T.A. et al. Association of sarcopenia and carotid atherosclerosis in elderly male patients with knee osteoarthritis. Russian Medical Inquiry. 2022;6(3):120–125 (in Russ.). DOI: 10.32364/2587-6821-2022-6-3-120-125.","PeriodicalId":21378,"journal":{"name":"Russian Medical Inquiry","volume":"93 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76727714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Russian Medical Inquiry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1